Bramante Biologics Analysis
What is Bramante Biologics?
Bramante Biologics is a US-based contract development and manufacturing organization focused on protein therapeutics. The company is part of the YCombinator X25 batch and operates from Cambridge, Massachusetts. It serves early-stage biotech companies with specialized capabilities in protein therapeutics development and manufacturing.
Location
Cambridge, United States
Employees
1-10
Founded
2024
Y Combinator Partner
Nicolas Dessaigne
YC Batch
X25
Yc Primary Partner
Nicolas Dessaigne
Product Features & Capabilities
- Pharmaceutical drugs manufactured faster in the USA, advanced biomanufacturing methods, modular container factories, expedited drug development, secure supply chains against geopolitical shocks, ensuring life-saving drugs reach patients up to a year sooner.
Who are the founders of Bramante Biologics
SS
Scott Stankey
Co-Founder
MM
Michael Magaraci
Co-Founder
Market Focus
The primary market that Bramante Biologics focuses on is the pharmaceutical industry, specifically in the area of biomanufacturing and protein therapeutics. They operate as a contract development and manufacturing organization (CDMO), utilizing advanced biomanufacturing methods and modular container factories to manufacture pharmaceutical drugs.
See something that needs updating? Suggest edits to this profile.